Imagen de Portada
Código QR

Antihyperglycemic drug linked to reduced risk of new onset AMD.

Publicado en:Ophthalmology Times Vol. 45; no. 16; p. 38
Autor principal: Guttman Krader, Cheryl
Formato: brief item Journal Article
Publicado: MJH Life Sciences 10/1/2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146330359&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 146330359
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0193032X
        OTI
      jtl: Ophthalmology Times
      issn: 0193032X
      maglogo: N
    pubinfo:
      dt: 10/1/2020
      vid: 45
      iid: 16
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        146330359
        146330359
        146330359
        146330359
      ppf: 38
      ppct: 0
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Antihyperglycemic drug linked to reduced risk of new onset AMD.
      aug:
        au: Guttman Krader, Cheryl
      sug:
        subj:
          Metformin Therapeutic Use
          Macular Degeneration Prevention and Control
          Diabetes Mellitus Drug Therapy
          Aging
      pubtype: Trade Publication
      doctype:
        brief item
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N